Latest close: a new 52-week highSep 8, 2026what changed →
The financials
Roivant Sciences Ltd. by the numbers
Roivant Sciences Ltd. (ROIV) reported revenue of $2.5M in Q4 2025 (quarter ended Mar 31, 2026), down 67% from the same quarter a year earlier. That came with net income of $303M (12024% of revenue). For the full year FY2025, revenue was $8.3M (−72% year on year) and net income −$300M.
| Income statement | Q4 2025 | Q4 2024 | Change |
|---|---|---|---|
| Revenue | $2.5M | $7.6M | −67% |
| Operating income | $415M | −$285M | to a profit |
| Net income | $303M | −$206M | to a profit |
| Diluted EPS | $0.34 | −$0.29 | to a profit |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $1.4M (-43%)
Reportable grew -34% year on year
Segment Latestquarter on quarteryear on year
- Reportable$1.4M$1.4MQoQ -43%year on year -34%-43%-34%
Biotechnology
Ranks #59 of 143 by Smart Score